OA9 OppAlerts AI Search Visibility & Ranking Factors
oppalerts.com →
Med Spas Aesthetic Clinics

Weight Loss Wellness Seeker

Knowledge Graph Entities
Dominant · Search Engine Appearances ρ=-0.301

AI recommendation signal analysis across 622 domains for the Weight Loss Wellness Seeker persona in Med Spas Aesthetic Clinics.

Download this report (.xlsx)
622Domains Tracked
10.3MReddit Posts
8,297Wikipedia Articles
1.8MOpen Web Matches
Weight Loss Wellness Seeker_persona.report
EntityScore
Mayo Clinic
60.0
Cleveland Clinic
60.0
International Society of Aesthetic Plastic Surgery
51.7
WW International
51.1
Obesity Medicine Association
51.1
Entitys rankedn = 25
Want a custom AI visibility audit for Med Spas Aesthetic Clinics?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch →
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Weight Loss Wellness Seeker. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

46K
Entities With Topic Matches
359
Entities Mentioning Brands
46K
Topic Phrase Matches
389
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

10 of 25 top domains for Weight Loss Wellness Seeker have a knowledge-graph entity.

DomainKnowledge Graph EntityWikidata ID
formhealth.coNot in the knowledge graph-
milanlaser.comMilan Laser Hair RemovalQ133042646
ro.coRomanQ48743480
clevelandclinic.orgCleveland ClinicQ4117596
idealimage.comNot in the knowledge graph-
calibrate.comNot in the knowledge graph-
equinox.comEquinox FitnessQ5384535
skinspirit.comNot in the knowledge graph-
weightwatchers.comWW InternationalQ1929466
joinmochi.comNot in the knowledge graph-
found.comNot in the knowledge graph-
joinfound.comNot in the knowledge graph-
laseraway.comLaserAwayQ119982751
nexthealth.comNot in the knowledge graph-
mayo.eduMayo School of Health SciencesQ6797552
mayoclinic.orgMayo ClinicQ1130172
knownwell.coNot in the knowledge graph-
hers.comNot in the knowledge graph-
calocure.comNot in the knowledge graph-
sequence.comNot in the knowledge graph-
pittsburghplasticsurgery.comNot in the knowledge graph-
plushcare.comPlushCareQ106752047
henryford.comHenry Ford HospitalQ3145166
renewmedandspa.comNot in the knowledge graph-
remedymeds.comNot in the knowledge graph-
25 domainsAll results shown
Wikidata

Top knowledge-graph entities

The entity records where Weight Loss Wellness Seeker's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.

EntityBlendedBrand MentionsTopic Matches
Mayo Clinic60.040
Cleveland Clinic60.040
International Society of Aesthetic Plastic Surgery51.730
WW International51.111
Obesity Medicine Association51.111
Profile Plan51.111
Massachusetts General Hospital41.020
The University of Texas MD Anderson Cancer Center41.020
University of Texas Southwestern Medical Center41.020
Center for Drug Evaluation and Research41.020
Henry Ford Health41.020
University of Pittsburgh Medical Center41.020
Virginia Mason Medical Center41.020
Wexner Medical Center at Ohio State University41.020
HealthGrades41.020
UCLA Health System41.020
NewYork-Presbyterian Westchester41.020
Forbes 30 Under 3041.020
Mayo Clinic Health System41.020
UPMC Health System41.020
Ohio State University Hospital41.020
Johns Hopkins Medicine41.020
Christopher R. Conley41.020
Q9660291441.020
Forbes ASAP41.020
WebMD Magazine41.020
Forbes Best-In-State Wealth Advisor41.020
Forbes Top 250 Wealth Advisor41.020
National Commissioning Guidelines: Body contouring surgery after massive weight loss40.002
Truncal body contouring surgery in the massive weight loss patient40.002
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity40.002
Complications following body contouring surgery after massive weight loss: a meta-analysis40.002
Body Image and Quality of Life in Post Massive Weight Loss Body Contouring Patients*40.002
Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial.40.002
Noninvasive radio frequency for skin tightening and body contouring40.002
Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence40.002
Body Contouring and Skin Tightening Using a Unique Novel Multisource Radiofrequency Energy Delivery Method40.002
Body contouring surgery in a massive weight loss patient: An overview40.002
Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.40.002
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.40.002
Tailoring dietary approaches for weight loss40.002
Dietary weight loss and exercise effects on insulin resistance in postmenopausal women40.002
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys40.002
Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques40.002
CD-ROM nutrient analysis database assists self-monitoring behavior of active duty Air Force personnel receiving nutrition counseling for weight loss40.002
Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men.40.002
The influence of calcium supplement on body composition, weight loss and insulin resistance in obese adults receiving low calorie diet.40.002
Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction40.002
Body contouring following massive weight loss40.002
Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age.40.002
Autophagy: A housekeeper in cardiorenal metabolic health and disease40.002
Risk of Thromboembolism Following Body-Contouring Surgery After Massive Weight Loss40.002
The potential of phototherapy to reduce body fat, insulin resistance and "metabolic inflexibility" related to obesity in women undergoing weight loss treatment40.002
Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance40.002
Body contouring after massive weight loss40.002
Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats40.002
Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss40.002
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.40.002
Effects of clinically significant weight loss with exercise training on insulin resistance and cardiometabolic adaptations40.002
Can early weight loss, eating behaviors and socioeconomic factors predict successful weight loss at 12- and 24-months in adolescents with obesity and insulin resistance participating in a randomised controlled trial?40.002
Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss40.002
Body contouring following major weight loss40.002
The BODY-Q: A Patient-Reported Outcome Instrument for Weight Loss and Body Contouring Treatments40.002
Effects of Diet Composition and Insulin Resistance Status on Plasma Lipid Levels in a Weight Loss Intervention in Women40.002
Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss40.002
Assessing Improvement in Quality of Life and Patient Satisfaction following Body Contouring Surgery in Patients with Massive Weight Loss: A Critical Review of Outcome Measures Employed40.002
Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial40.002
Changing Body Image and Well-Being: Following the Experience of Massive Weight Loss and Body Contouring Surgery40.002
Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss40.002
Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals40.002
Seroma development following body contouring surgery for massive weight loss: patient risk factors and treatment strategies40.002
Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects40.002
Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide.40.002
Body contouring and weight loss surgery for obesity40.002
Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss40.002
Does Regular Exercise without Weight Loss Reduce Insulin Resistance in Children and Adolescents?40.002
A comparative analysis and systematic review of the wound-healing milieu: implications for body contouring after massive weight loss40.002
Discussion. A comparative analysis and systematic review of the wound-healing milieu: implications for body contouring after massive weight loss40.002
Outpatient-Based Massive Weight Loss Body Contouring: A Review of 260 Consecutive Cases40.002
Commentary on: Outpatient-Based Massive Weight Loss Body Contouring: A Review of 260 Consecutive Cases40.002
Aesthetic refinements in body contouring in the massive weight loss patient: Part 2. Arms40.002
Aesthetic Refinements in Body Contouring in the Massive Weight Loss Patient40.002
Updates in weight loss surgery and gastrointestinal peptides40.002
A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements40.002
Painless, safe, and efficacious noninvasive skin tightening, body contouring, and cellulite reduction using multisource 3DEEP radiofrequency.40.002
Utilization of Body Contouring Procedures Following Weight Loss Surgery: A Study of 37,806 Patients40.002
Patient-Reported Outcomes in Weight Loss and Body Contouring Surgery: A Cross-Sectional Analysis Using the BODY-Q.40.002
The Impact of Body Contouring Procedures on Urologic Outcomes in Massive Weight Loss Patients40.002
How family interactions about lifestyle changes affect adolescents' possibilities for maintaining weight loss after a weight-loss intervention: a longitudinal qualitative interview study.40.002
Body Contouring Surgery in the Massive Weight Loss Patient40.002
Implementation of national body contouring surgery guidelines following massive weight loss: A national cross-sectional survey of commissioning in England.40.002
Body contouring after obesity surgery is associated with a weight loss benefit among patients40.002
Body contouring procedures in three or more anatomical areas are associated with long-term body mass index decrease in massive weight loss patients: A retrospective cohort study40.002
Impact of Body Contouring Procedures on Post-Bariatric Surgery Weight Loss40.002
EFFECTS OF OATS ON LIPID PROFILE, INSULIN RESISTANCE AND WEIGHT LOSS40.002
Complications in body contouring stratified according to weight loss method.40.002
Insurance coverage for massive weight loss panniculectomy: a national survey and implications for policy40.002
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice40.002
Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women40.002
Post-Bariatric Body Contouring Surgery After Weight Loss: Lessons Learned From an Obesity Epidemic in the United States40.002
Lifestyle Changes Aiming at Weight Loss Should Always Be Included in the Treatment of Obese Patients with Obstructive Sleep Apnea40.002
Maintenance of weight loss after body contouring surgery for massive weight loss40.002
Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss40.002
Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance40.002
The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: an observational retrospective clinical program analysis40.002
High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers?40.002
Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets.40.002
Former small for gestational age (SGA) status is associated to changes of insulin resistance in obese children during weight loss40.002
Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance40.002
Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs.40.002
Insulin resistance precedes weight loss in adults without diabetes : the Rancho Bernardo Study40.002
Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women40.002
Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity40.002
Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure40.002
A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss40.002
Association between Blood Pressure and Insulin Resistance in Obese Females during Weight Loss and Weight Rebound Phenomenon40.002
The Effect of Massive Weight Loss Status, Amount of Weight Loss, and Method of Weight Loss on Body Contouring Outcomes40.002
Body contouring in the male weight loss population: assessing gender as a factor in outcomes40.002
Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome40.002
Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content40.002
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial40.002
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients40.002
Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes40.002
Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial40.002
Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients40.002
Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes40.002
Psychometric Validation of the BODY-Q in Danish Patients Undergoing Weight Loss and Body Contouring Surgery40.002
Cortisol and its relation to insulin resistance before and after weight loss in obese children40.002
Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis40.002
Differential effect of weight loss on insulin resistance in surgically treated obese patients.40.002
Desire for body contouring surgery after bariatric surgery: do body mass index and weight loss matter?40.002
Weight loss in obese prepubertal children: the influence of insulin resistance40.002
Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet.40.002
A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss40.002
Book Review: Body Contouring After Massive Weight Loss40.002
After massive weight loss: patients' expectations of body contouring surgery.40.002
The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans40.002
Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets40.002
Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance40.002
Influence of G308A promoter variant of tumor necrosis factor-alpha gene on insulin resistance and weight loss secondary to two hypocaloric diets: a randomized clinical trial.40.002
Weight loss on low‐fat vs. low‐carbohydrate diets by insulin resistance status among overweight adults and adults with obesity: A randomized pilot trial40.002
Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance40.002
Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding40.002
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.40.002
Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions40.002
Dietary restriction and Sirtuin 1 in metabolic health: connections and divergences40.002
Long-term effects of popular dietary approaches on weight loss and features of insulin resistance40.002
Commentary on: Outpatient-based massive weight loss body contouring: a review of 260 consecutive cases40.002
Effect of weight loss on blood pressure, arterial compliance, and insulin resistance in normotensive obese subjects40.002
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes40.002
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels40.002
National bariatric surgery and massive weight loss body contouring survey40.002
Sciatic neuropathy after body contouring surgery in massive weight loss patients40.002
Role of rs1501299 variant in the adiponectin gene on total adiponectin levels, insulin resistance and weight loss after a Mediterranean hypocaloric diet.40.002
Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism40.002
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients40.002
Discussion: Patient-Reported Outcomes in Weight Loss and Body Contouring Surgery: A Cross-Sectional Analysis Using the BODY-Q.40.002
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss40.002
Implications of weight loss method in body contouring outcomes40.002
Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach40.002
Low-calorie diet induced weight loss may alter regulatory hormones and contribute to rebound visceral adiposity in obese persons with a family history of type-2 diabetes40.002
Body Contouring After Massive Weight Loss: A Personal Integrated Approach40.002
Comparison of simple indices for measuring insulin resistance that integrates adipokines in non-diabetic obese postmenopausal women before and after weight loss: A MONET study40.002
The rs10401670 variant in resistin gene improved insulin resistance response and metabolic parameters secondaries to weight loss after a hypocaloric diet40.002
Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries40.002
Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss.40.002
Periparturient dairy cows do not exhibit hepatic insulin resistance, yet adipose-specific insulin resistance occurs in cows prone to high weight loss40.002
Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men.40.002
Diminished insulin resistance with weight loss in severely overweight youth40.002
One-year effectiveness of two hypocaloric diets with different protein/carbohydrate ratios in weight loss and insulin resistance40.002
The rs1862513 Variant in Resistin Gene-Modified Insulin Resistance and Insulin Levels after Weight Loss Secondary to Hypocaloric Diet40.002
Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss40.002
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss40.002
Body contouring after massive weight loss - case report40.002
Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients40.002
Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial40.002
Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status40.002
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss40.002
Insulin resistance predicts the effectiveness of different glycemic index diets on weight loss in non-obese women.40.002
The impact of rapid weight loss (4%) on leptin, adiponectin, and insulin resistance in elite adult free style wrestlers40.002
Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss40.002
Attitudes of morbidly obese patients to weight loss and body image following bariatric surgery and body contouring40.002
Effects of Trp64Arg Mutation in the β3-Adrenergic Receptor Gene on Weight Loss, Body Fat Distribution, Glycemic Control, and Insulin Resistance in Obese Type 2 Diabetic Patients40.002
Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome40.002
Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”40.002
Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women40.002
Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass40.002
An outcomes analysis of patients undergoing body contouring surgery after massive weight loss40.002
Body contouring surgery for military personnel following massive weight loss40.002
Lifestyle medicine consulting walking meetings for sustained weight loss.40.002
HDL-sphingomyelin reduction after weight loss by an energy-restricted diet is associated with the improvement of lipid profile, blood pressure, and decrease of insulin resistance in overweight/obese patients40.002
Body contouring after weight loss: the plastic-bariatric surgery symbiosis40.002
Weight loss is higher among patients who undergo body contouring procedures after bariatric surgery40.002
Body contouring after weight loss in morbid obesity: gain in health and leap in psychosocial functioning40.002
Supplementation of n3 Long-chain Polyunsaturated Fatty Acid Synergistically Decreases Insulin Resistance with Weight Loss of Obese Prepubertal and Pubertal Children40.002
The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss40.002
Complications in postbariatric body contouring based on different weight loss methods40.002
Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals40.002
Metformin and placebo therapy in adjunct with lifestyle intervention both improve weight loss and insulin resistance in obese adolescents40.002
Body contouring following massive weight loss resulting from bariatric surgery40.002
Impact of Body Contouring Procedures on Maintenance of Post-Bariatric Weight Loss40.002
Altered Insulin Resistance Is Associated with Increased Dietary Weight Loss in Obese Children40.002
Body contouring procedures for massive weight loss patients and their complications40.002
ROLE OF RS9939609 FTO GENE VARIANT IN WEIGHT LOSS, INSULIN RESISTANCE AND METABOLIC PARAMETERS AFTER A HIGH MONOUNSATURATED VS A HIGH POLYUNSATURATED FAT HYPOCALORIC DIETS.40.002
Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children40.002
Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet40.002
Utility Assessment of Body Contouring After Massive Weight Loss40.002
Exercise-Induced Weight Loss Is More Effective Than Dieting for Improving Adipokine Profile, Insulin Resistance, and Inflammation in Obese Men40.002
On the multiple-procedure approach to body contouring in the massive weight loss patient40.002
Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women40.002
Discussion: Prospective Assessment of Nutrition and Exercise Parameters before Body Contouring Surgery: Optimizing Attainability in the Massive Weight Loss Population40.002
Prospective Assessment of Nutrition and Exercise Parameters before Body Contouring Surgery: Optimizing Attainability in the Massive Weight Loss Population40.002
A preliminary report on the development of a validated tool for measuring psychosocial outcomes for massive weight loss patients40.002
Inflammatory status is different in relationship to insulin resistance in severely obese people and changes after bariatric surgery or diet-induced weight loss40.002
Low-grade inflammation in overweight and obese adults is affected by weight loss program40.002
Chylomicron-Derived Fatty Acid Spillover in Adipose Tissue: A Signature of Metabolic Health?40.002
HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: the POUNDS Lost and DIRECT trials40.002
Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors40.002
Insulin Resistance Improves More in Women than In Men in Association with a Weight Loss Intervention40.002
Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial40.002
Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons.40.002
Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes.40.002
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers40.002
Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines40.002
Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes40.002
Body image dissatisfaction and depression in postbariatric patients is associated with less weight loss and a desire for body contouring surgery40.002
Erratum to: Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months’ consumption of a combination of bioactive food ingredients in overweight subjects40.002
Does Body Contouring After Bariatric Weight Loss Enhance Quality of Life? A Systematic Review of QOL Studies40.002
A Review of the Use of Ultrasound for Skin Tightening, Body Contouring, and Cellulite Reduction in Dermatology40.002
Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss40.002
The Metabolic Effects of Different Weight Loss Diets40.002
Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents40.002
Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Longitudinal Study40.002
Physiological Factors That Influence Maintenance of Lifestyle Changes and Weight Loss - a Cross-sectional Study40.002
Progressive Weight Loss and Metabolic Health40.002
Weight Loss and Reversing T2D Through eHealth Coaching40.002
Effect of Lifestyle Changes on BDNF Level After Stroke40.002
Weight Loss Diet Study: Low Carb vs Low Fat40.002
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women40.002
Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes40.002
Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community40.002
The Effects of a Moderate Weight Loss on Insulin Resistance40.002
Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health40.002
Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health40.002
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children40.002
Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss40.002
Gene Expression in Obesity and Insulin Resistance40.002
Forearm Immobilization, Metabolic Health, and Muscle Loss40.002
Pre-operative Exercise and Nutrition Therapy on Cardio-metabolic Health in Patients Undergoing Bariatric Surgery40.002
2-5 Intermittent Caloric Restriction for Weight Loss and Insulin Resistance in HIV-Infected Adults With Features of the Metabolic Syndrome40.002
Body Contouring Surgery After Massive Weight Loss40.002
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss40.002
Efficacy of a Web-based Weight Loss Program40.002
Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance40.002
Impact of Protein Quantity Within the USDA Healthy Style Eating Pattern on Sleep40.002
Smart Technology for Weight Loss and Metabolic Health40.002
Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults40.002
Effects of tumor removal and body weight loss on insulin resistance in patients with cancer40.002
Effects of tumor removal and body weight loss on insulin resistance: preliminary report40.002
Diet for the Maintenance of Weight Loss and Metabolic Health in Obese Postmenopausal Women40.002
High-intensity Interval Training for Obese Individuals40.002
Body contouring surgery after massive weight loss. Part I: abdomen and extremities40.002
Body contouring surgery in the massive weight loss patient40.002
Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women40.002
Body contouring following massive weight loss40.002
Body contouring surgery after massive weight loss40.002
Influence of G308A polymorphism of tumor necrosis factor alpha gene on insulin resistance in obese patients after weight loss40.002
Informed consent for body contouring procedures in the massive weight loss patient40.002
Body contouring after weight loss surgery40.002
Body contouring after massive weight loss40.002
Body contouring after massive weight loss40.002
The effect of weight loss on serum concentration of interleukine-6 (IL-6) and insulin resistance40.002
Even moderate weight loss can lower your heart risk. Research shows that strength training and aerobic exercise can help sedentary seniors decrease their risk for insulin resistance40.002
Body contouring following massive weight loss40.002
METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT40.002
Using the BODY-Q to Understand Impact of Weight Loss, Excess Skin, and the Need for Body Contouring following Bariatric Surgery40.002
Role of rs670 variant of APOA1 gene on lipid profile, insulin resistance and adipokine levels in obese subjects after weight loss with a dietary intervention40.002
Discussion: Using the BODY-Q to Understand Impact of Weight Loss, Excess Skin, and the Need for Body Contouring following Bariatric Surgery40.002
Family Physicians' Perspectives on Their Weight Loss Nutrition Counseling in a High Obesity Prevalence Area40.002
The Relationship between Circulating Acetate and Human Insulin Resistance before and after Weight Loss in the DiOGenes Study40.002
Setting realistic expectations for weight loss after laparoscopic sleeve gastrectomy40.002
Effect of Lifestyle Coaching Including Telemonitoring and Telecoaching on Gestational Weight Gain and Postnatal Weight Loss: A Systematic Review40.002
Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial40.002
Skin Protein Profile after Major Weight Loss and Its Role in Body Contouring Surgery40.002
Complications after lower body contouring surgery due to massive weight loss unaffected by weight loss method40.002
Endocrine-Metabolic Response in Patients Undergoing Multiple Body Contouring Surgeries After Massive Weight Loss40.002
Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES40.002
Author Correction: Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial40.002
Aspects of excess skin in obesity, after weight loss, after body contouring surgery and in a reference population40.002
Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention?40.002
Reply to "The Assessment of a Predictive Risk and a Decrease Postoperative Complication Following Body Contouring Surgery after Massive Weight Loss"40.002
Streamlining the Assessment of Patient-Reported Outcomes in Weight Loss and Body Contouring Patients: Applying Computerized Adaptive Testing to the BODY-Q40.002
Knowledge is power: Providing previsit insurance coverage information of body contouring procedures to improve understanding and satisfaction in the massive weight loss patient40.002
Body Contouring Surgery after Massive Weight Loss: Excess Skin, Body Satisfaction, and Qualification for Reimbursement in a Dutch Post-Bariatric Surgery Population40.002
CORRIGENDUM FOR "Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide"40.002
Body Contouring Following Massive Weight Loss: the Evolving Role of Plastic Surgeons and Risk Stratification Tools40.002
Effect of high dose vitamin D supplementation in combination with weight loss diet on Glucose homeostasis, insulin resistance and matrix metalloproteinases in obese subjects with vitamin D deficiency: a double blind placebo-controlled randomized cli40.002
Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery40.002
Comparison of the Moorehead-Ardelt quality of life questionnaire and the BODY-Q in Danish patients undergoing weight loss and body contouring surgery40.002
Review of non-invasive body contouring devices for fat reduction, skin tightening and muscle definition40.002
Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide40.002
Body Contouring Surgery Improves Physical Activity in Patients After Massive Weight Loss-a Retrospective Study40.002
Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities40.002
Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats40.002
Body Contouring After Massive Weight Loss40.002
More Frequent Nutrition Counseling Limits Weight Loss and Improves Energy Intake During Oncology Management: A Longitudinal Inpatient Study in Taiwan40.002
Commentary on: Endocrine-Metabolic Response in Patients Undergoing Multiple Body Contouring Surgeries After Massive Weight Loss40.002
Body Contouring after Massive Weight Loss40.002
[Effect of lifestyle changes on weight loss and weight loss maintenance]40.002
RS9939609 FTO gene variant modified weight loss and insulin resistance after a partial meal-replacement hypocaloric diet40.002
Nondigestible Carbohydrates Affect Metabolic Health and Gut Microbiota in Overweight Adults after Weight Loss40.002
Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients With OA40.002
[POST MASSIVE WEIGHT LOSS BODY CONTOURING SURGERIES CONTRIBUTE SIGNIFICANTLY TO OBESITY TREATMENT]40.002
The Impact of Abdominal Body Contouring Surgery on Physical Function After a Massive Weight Loss (BCSP)40.002
Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver40.002
Body Contouring Surgery Improves Weight Loss after Bariatric Surgery: A Systematic Review and Meta-Analysis40.002
A circadian rhythm-related MTNR1B genetic variant (rs10830963) modulates glucose metabolism and insulin resistance after body weight loss secondary to biliopancreatic diversion surgery40.002
Intensive nutrition counseling as part of a multi-component weight loss intervention improves diet quality and anthropometrics in older adults with obesity40.002
Weight loss through lifestyle changes: impact in the primary prevention of cardiovascular diseases40.002
Effect of a weight loss program on serum adiponectin and insulin resistance among overweight and obese premenopausal females40.002
A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults40.002
Novel Combination of Exercise and Carbohydrate Restriction for Metabolic Health40.002
Prevalence rates of metabolic health and body size phenotypes by different criteria and association with insulin resistance in a Maltese Caucasian population40.002
Forearm Immobilization, Metabolic Health, and Nutrition40.002
Adipose methylome integrative-omic analyses reveal genetic and dietary metabolic health drivers and insulin resistance classifiers40.002
Metabolic health and lifestyle medicine should be a cornerstone of future pandemic preparedness40.002
Incorporating Nutrition Counseling into Lifestyle Medicine40.002
Efficacy of Liraglutide: GLP 1 Receptor Agonist on Glycemic Control and Weight Loss among Patients with Type 2 Diabetes40.002
Insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity40.002
Sa1627 – Effect of a Ketogenic Weight Loss Protocol on Liver Enzymes, Fibrosis Scores, and Features of Insulin Resistance in Nash Patients40.002
A 10-Week Pedometer-Based Walking Program Induced Weight Loss and Improved Metabolic Health in Community-Dwelling Adults40.002
Effect of regular physical activity and lifestyle changes on insulin resistance in patients after kidney transplantation40.002
The Art and Science beyond Body Contouring A Solution for Massive Weight Loss Patients40.002
Impact of short term weight loss (very low calorie diet vs bariatric surgery) on hepatic insulin resistance and plasma lipidomic profile40.002
Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials40.002
Q13597033640.002
dietary counselling40.002
Q13678842540.002
Juniper (telehealth company)40.002
Solas Health & Wellness40.002
Greenwich Medical Spa40.002
The Forward25.810
United States Food and Drug Administration25.810
ADVFN25.810
Harold E. Varmus25.810
McKinsey & Company25.810
Allure25.810
The World's Billionaires25.810
Q63619225.810
Johns Hopkins School of Medicine25.810
Forbes25.810
NewYork–Presbyterian Hospital25.810
The World's Most Powerful People25.810
Forbes Global 200025.810
Mike Lazaridis25.810
Johns Hopkins Hospital25.810
Mount Sinai Hospital25.810
polymyalgia rheumatica25.810
Memorial Sloan Kettering Cancer Center25.810
McKinsey Quarterly25.810
Lou Ruvo Center for Brain Health25.810
CVS Pharmacy25.810
UCLA Ronald Reagan Medical Center25.810
Mayo Clinic Hospital — Rochester25.810
Forbes 40025.810
Vattikuti Urology Institute25.810
Henry Ford Hospital25.810
WebMD25.810
Johns Hopkins All Children's Hospital25.810
Henry Ford Jackson Hospital25.810
Amen Clinic25.810
American Academy of Anti-Aging Medicine25.810
American Society of Plastic Surgeons25.810
ArrayTrack25.810
Arthur L. Jenkins25.810
Bad Bug Book25.810
Banner Health25.810
Canyon Ranch25.810
Northwestern Medicine McHenry Hospital25.810
Center for Biologics Evaluation and Research25.810
Center for Devices and Radiological Health25.810
Center for Food Safety and Applied Nutrition25.810
Center for Tobacco Products25.810
Center for Veterinary Medicine25.810
Central DuPage Hospital25.810
Corinne Goldsmith Dickinson Center for Multiple Sclerosis25.810
Doximity25.810
Equinox Fitness25.810
Forsyth Medical Center25.810
Franciscan Skemp Medical Center25.810
Harborview Medical Center25.810
HealthPartners25.810
Howard County General Hospital25.810
UCLA Jules Stein Eye Institute25.810
Mayo Clinic Hospital – Jacksonville25.810
Mayo School of Health Sciences25.810
MedStar Health25.810
Medical News Today25.810
Morgan Stanley Children's Hospital25.810
NYU Langone Health25.810
National Center for Toxicological Research25.810
National Rehabilitation Hospital25.810
NewYork-Presbyterian Healthcare System25.810
Lower Manhattan Hospital25.810
Weill Cornell Medical Center25.810
Northwest Hospital & Medical Center25.810
Office of Criminal Investigations25.810
Mass General Brigham25.810
Novant Health Presbyterian Medical Center25.810
Presbyterian Hospital Huntersville25.810
Red Wing Medical Center25.810
Richard M. Ross Heart Hospital25.810
Scripps Mercy Hospital25.810
Scripps Health25.810
Sibley Memorial Hospital25.810
Sofia Frangou25.810
Stanford Hospital and Clinics25.810
Stanford University Medical Center25.810
Thomasville Medical Center25.810
UCLA Santa Monica Medical Center25.810
UCSF Medical Center25.810
UPMC Hamot25.810
UPMC Mercy25.810
UPMC Mercy South Side Outpatient Center25.810
UPMC St. Margaret25.810
University of Washington Medical Center25.810
University of Washington School of Medicine25.810
Victor Velculescu25.810
Virginia Mason Hospital25.810
WWAMI Regional Medical Education Program25.810
Washington Hospital Center25.810
Zocdoc25.810
Forbes' list of the world's highest-paid athletes25.810
Johns Hopkins Bayview Medical Center25.810
Novant Health Brunswick Medical Center25.810
Jefferson Health25.810
Novant Health25.810
Q1611739025.810
Mohamed Mansour25.810
Immanuel St. Joseph's25.810
Healthline25.810
Suburban Hospital25.810
MedicineNet25.810
Airlift Northwest25.810
Edward Thomas Ryan25.810
Andrew Vickers25.810
Lorenz Studer25.810
Robert Y. Moore25.810
Hudson Valley Hospital25.810
NewYork–Presbyterian/Queens25.810
William G. Nelson25.810
RealSelf25.810
beBee25.810
Charles Limb25.810
Joseph John Klimek25.810
Mayo Clinic Graduate School of Biomedical Sciences25.810
Forbes25.810
major depressive disorder25.201
anorexia nervosa25.201
bariatric surgery25.201
hyperemesis gravidarum25.201
glucagon-like peptide-125.201
mesotherapy25.201
emaciation25.201
metabolic syndrome25.201
weight loss25.201
reducing diet25.201
weight cycling25.201
insulin resistance25.201
pedicure25.201
screening25.201
anti-obesity medication25.201
nutritional consulting25.201
William Banting25.201
bariatric medicine25.201
low-glycemic diet25.201
Cabbage soup diet25.201
lifestyle medicine25.201
The China Study25.201
healthy weight loss25.201
glucose intolerance25.201
type 2 diabetes25.201
Scarsdale diet25.201
rapid diagnostic test25.201
Valérie Orsoni25.201
Extreme Weight Loss25.201
ileitis25.201
weight loss product25.201
American Journal of Lifestyle Medicine25.201
body shaping25.201
CalorieKing25.201
cervical screening25.201
CherFitness: Body Confidence25.201
Cigarette smoking for weight loss25.201
Eva Orsmond25.201
Eskatrol25.201
Facial rejuvenation25.201
GSK71615525.201
Glasgow-Blatchford score25.201
HAIR-AN syndrome25.201
Hard keeper25.201
Herbal Magic25.201
Cuestión de peso25.201
homeostatic model assessment25.201
ileocolitis25.201
cachexia25.201
Jenny Craig, Inc.25.201
My Weight Loss Coach25.201
National Weight Control Registry25.201
Nutrisystem25.201
Category:Weight loss25.201
Online weight loss plans25.201
PEERtrainer25.201
Revision weight loss surgery25.201
Skinny Bitch25.201
Slimming World25.201
sustentacular cell25.201
The Weight-Loss Cure "They" Don't Want You to Know About25.201
Trim and Fit25.201
Weight Loss25.201
Weight Loss25.201
Weight Wins25.201
weight cutting25.201
Weight loss coaching25.201
Weight loss effects of water25.201
Wellspring camps25.201
Solanka Park in Inowrocław25.201
day spa25.201
Category:Weight loss companies25.201
Category:GLP-1 receptor agonists25.201
Journal of Medical Screening25.201
Charles D'Angelo25.201
secondary diabetes25.201
Eat to Live25.201
Weight loss25.201
NHS health check25.201
breast cancer screening25.201
Weight loss camp25.201
Retrofit25.201
medical surveillance25.201
Wtlr125.201
Wtlr225.201
Wtlr325.201
Wtlr425.201
Type 3 diabetes25.201
overscreening25.201
Therapeutic Lifestyle Changes25.201
typhoidal tularemia25.201
gastroduodenal Crohn's disease25.201
lung carcinoma25.201
Free Being Me25.201
The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome25.201
High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity25.201
Reduced Serotonin Reuptake Transporter (SERT) Function Causes Insulin Resistance and Hepatic Steatosis Independent of Food Intake25.201
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse25.201
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population25.201
Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men25.201
DHEA administration and exercise training improves insulin resistance in obese rats25.201
High-Protein Weight Loss Diets and Purported Adverse Effects: Where is the Evidence?25.201
Intramyocellular lipid kinetics and insulin resistance25.201
Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group25.201
Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study25.201
Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report25.201
The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians25.201
Evolutionary origins of insulin resistance: a behavioral switch hypothesis25.201
Emphasising Personal Investment Effects Weight Loss and Hedonic Thoughts about Food after Obesity Surgery25.201
Insulin Resistance in Patients with Chronic Kidney Disease25.201
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions25.201
The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials25.201
The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials25.201
Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study25.201
Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss25.201
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension25.201
Diet in the management of weight loss25.201
New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF-  Inhibitors, and GLP-1 Receptor Agonists25.201
Inflammation and insulin resistance25.201
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss25.201
Obesity, Inflammation, and Insulin Resistance25.201
Cancer is a preventable disease that requires major lifestyle changes25.201
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance25.201
An approach to the management of unintentional weight loss in elderly people25.201
Obesity medicine25.201
Medical screening of office workers for upper extremity cumulative trauma disorders25.201
Mortality among sheet metal workers participating in a medical screening program25.201
Workplace-Based Participatory Approach to Weight Loss for Correctional Employees25.201
Symptom onset in the first 2 years of employment at a wood products plant using diisocyanates: some observations relevant to occupational medical screening25.201
The use of biomarkers in surveillance, medical screening, and intervention25.201
Standardization of spirometry in assessment of responders following man-made disasters: World Trade Center worker and volunteer medical screening program25.201
Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss25.201
The World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening program25.201
The effects of two workplace weight management programs and weight loss on health care utilization and costs25.201
excess skin25.201
A clinical trial on weight loss among truck drivers25.201
Psychosocial interventions for the maintenance of weight loss in obese adults25.201
Commercial weight loss products and services for obese and overweight adults25.201
Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance25.201
Lifestyle changes for treating psoriasis25.201
Surgery for weight loss in adults25.201
Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors25.201
Chinese herbal medicines for weight loss25.201
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis25.201
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis25.201
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults25.201
Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people25.201
Weight loss interventions for chronic asthma25.201
Commercial weight loss products and services for obese and overweight adults25.201
Green tea for weight loss and weight maintenance in overweight or obese adults25.201
Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults25.201
Interventions for fatigue and weight loss in adults with advanced progressive illness25.201
Lifestyle changes in women with polycystic ovary syndrome25.201
Weight loss interventions for chronic asthma25.201
Lifestyle changes in women with polycystic ovary syndrome25.201
Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults25.201
Green tea for weight loss and weight maintenance in overweight or obese adults25.201
Interventions for fatigue and weight loss in adults with advanced progressive illness25.201
Computer-based interventions for weight loss or weight maintenance in overweight or obese people25.201
Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults25.201
Lifestyle changes in women with Polycystic Ovary Syndrome25.201
Chinese herbal medicines for weight loss25.201
Psychosocial interventions for the maintenance of weight loss in obese adults25.201
Weight loss for primary prevention of stroke in people with overweight or obesity25.201
Long-term non-pharmacological weight loss interventions for adults with prediabetes25.201
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus25.201
Anabolic steroids for the treatment of weight loss in HIV-infected individuals25.201
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis25.201
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis25.201
Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus25.201
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus25.201
Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes25.201
Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance25.201
Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes25.201
Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes25.201
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance25.201
Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome25.201
S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK225.201
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes25.201
The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents25.201
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus25.201
Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis25.201
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance25.201
An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance25.201
Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism25.201
The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease25.201
Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesity25.201
A syndrome of insulin resistance resembling leprechaunism in five sibs of consanguineous parents25.201
Insulin and insulin resistance.25.201
The Use of Nonprescription Weight Loss Products Among Female Basketball, Softball, and Volleyball Athletes from NCAA Division I Institutions: Issues and Concerns.25.201
The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance25.201
Hexosamines, insulin resistance, and the complications of diabetes: current status25.201
Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods25.201
Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance25.201
Fructose, insulin resistance, and metabolic dyslipidemia25.201
Thermodynamics of weight loss diets25.201
Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance25.201
Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler25.201
Mechanism of free fatty acid-induced insulin resistance in humans25.201
Liposuction does not achieve metabolic benefits of weight loss25.201
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse25.201
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity25.201
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies25.201
Weight loss to treat urinary incontinence in overweight and obese women25.201
The endothelium abridges insulin resistance to premature aging25.201
Obesity and insulin resistance25.201
Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil25.201
Hydroxycut(®) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature25.201
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance25.201
Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes25.201
Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance25.201
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance25.201
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance25.201
The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control25.201
Nesfatin-1 Action in the Brain Increases Insulin Sensitivity Through Akt/AMPK/TORC2 Pathway in Diet-Induced Insulin Resistance25.201
Science of weight loss supplements: Compromised by conflicts of interest?25.201
Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial25.201
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction25.201
Water consumption increases weight loss during a hypocaloric diet intervention in middle-aged and older adults25.201
Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet25.201
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study25.201
Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population25.201
Effect of exercise on 24-month weight loss maintenance in overweight women25.201
The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study25.201
FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue25.201
Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans25.201
Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements25.201
Weight loss during the intensive intervention phase of the weight-loss maintenance trial25.201
Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia25.201
Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial25.201
Realistic expectations of prepulse inhibition in translational models for schizophrenia research25.201
Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome25.201
The effects of exercise and weight loss in overweight patients with hip osteoarthritis: design of a prospective cohort study25.201
Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation25.201
IRS1-independent defects define major nodes of insulin resistance25.201
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance25.201
Insulin resistance is a cellular antioxidant defense mechanism25.201
Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans25.201
Revisiting leptin's role in obesity and weight loss25.201
Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery25.201
D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance25.201
Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss25.201
Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study25.201
Explanations for weight loss after ileojejunal bypass in gross obesity25.201
BRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between?25.201
Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males25.201
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats25.201
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression25.201
A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion25.201
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF125.201
History of medical screening: from concepts to action25.201
Longitudinal follow-up of patients evaluated for complaints related to nonindustrial indoor environments: symptoms, work and lifestyle changes25.201
Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study25.201
Weight loss dynamics during combined fluoxetine and olanzapine treatment25.201
Are the effects of nicotinic acid on insulin resistance precipitated by abnormal phosphorous metabolism?25.201
Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians25.201
The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians25.201
Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects25.201
Diet and physical activity behavior among users of prescription weight loss medications25.201
Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey25.201
Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial25.201
Who will lose weight? A reexamination of predictors of weight loss in women25.201
Reporting quality of randomized trials in the diet and exercise literature for weight loss25.201
Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey25.201
The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution25.201
Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women25.201
Prevention of Cancer Through Lifestyle Changes25.201
Type 2 Diabetes: Insulin Resistance May Be the Result of Mitochondrial Dysfunction25.201
Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction25.201
Insulin resistance in adolescents with Down syndrome: a cross-sectional study25.201
A 61-year-old man with dyspepsia and weight loss25.201
Weight loss and mortality: what does the evidence show?25.201
Weight Loss and Mortality25.201
Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats25.201
Insulin resistance in the offspring of parents with type 2 diabetes25.201
Diet induced weight loss accelerates onset of negative alliesthesia in obese women25.201
Medical screening for chronic beryllium disease in Massachusetts25.201
Current intelligence bulletin 60: interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles25.201
Radio Frequency skin tightening25.201
Continued process verification25.201
The relationship between prevalence and duration of weight loss strategies and weight loss among overweight managed care organization members enrolled in a weight loss trial25.201
healthy lifestyle25.201
Symptom onset in the first two years of employment at a wood products plant: some observations relevant to occupational medical screening25.201
Surveillance and health screening in occupational health25.201
Quality of spirometry performed by 13,599 participants in the World Trade Center Worker and Volunteer Medical Screening Program25.201
Surveillance, medical screening, and intervention25.201
Conference on medical screening and biological monitoring for the effects of exposure in the workplace, July 1984, part I25.201
Medical screening in the workplace: proposed principles25.201
Conference on medical screening and biological monitoring for the effects of exposure in the workplace, July 1984, Part II25.201
Role of medical screening in the prevention of occupational disease25.201
Guidelines for medical screening in the workplace25.201
Medical screening using periodic spirometry for detection of chronic lung disease25.201
Medical screening and biological monitoring: a guide to the literature for physicians25.201
Conference on Medical Screening and Biological Monitoring for the Effects of Exposure in the Workplace, July 10-13, 1984, Cincinnati, Ohio, program and presentation abstracts, July 198425.201
Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults25.201
Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gain25.201
Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors25.201
Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System25.201
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans25.201
Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates25.201
Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients25.201
Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders25.201
The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance25.201
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss25.201
Using Metabolomic Profiles as Biomarkers for Insulin Resistance in Childhood Obesity: A Systematic Review25.201
Selective Insulin Resistance in the Kidney25.201
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?25.201
Through Thick and Thin: Identifying Barriers to Bariatric Surgery, Weight Loss Maintenance, and Tailoring Obesity Treatment for the Future25.201
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism25.201
The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension25.201
Increased Hydration Can Be Associated with Weight Loss25.201
Genetics of Insulin Resistance and the Metabolic Syndrome25.201
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials25.201
Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction25.201
Roles of Reactive Oxygen Species on Insulin Resistance in Adipose Tissue25.201
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives25.201
Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management25.201
Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan25.201
A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle25.201
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials25.201
Insulin resistance in development and progression of nonalcoholic fatty liver disease25.201
Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals25.201
Weight change among people randomized to minimal intervention control groups in weight loss trials25.201
Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models25.201
Using Drosophila to discover mechanisms underlying type 2 diabetes25.201
Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels25.201
The association between PGC-1α and Alzheimer's disease25.201
Long-term weight loss maintenance for obesity: a multidisciplinary approach25.201
GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity25.201
Hepatitis C Virus, Insulin Resistance, and Steatosis25.201
The Impact of Automated Brief Messages Promoting Lifestyle Changes Delivered Via Mobile Devices to People with Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Controlled Trials25.201
A clinical perspective of obesity, metabolic syndrome and cardiovascular disease25.201
The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis25.201
Adiponectin signaling and function in insulin target tissues25.201
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities25.201
A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus25.201
Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS25.201
Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic health25.201
EJE PRIZE 2015: How does insulin resistance arise, and how does it cause disease? Human genetic lessons25.201
The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus25.201
Adipose tissue macrophages: going off track during obesity25.201
Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance25.201
Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective25.201
Low Salt Diet and Insulin Resistance25.201
Prediabetes and alzheimer's disease25.201
Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future25.201
Skeletal Muscle Mitochondrial Bioenergetics and Morphology in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat Source25.201
Diabetes mellitus in elderly25.201
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress25.201
Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease25.201
Hepatitis C and insulin action: An intimate relationship25.201
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy25.201
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss25.201
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?25.201
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man25.201
Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity25.201
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer25.201
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance25.201
Mobile Phone Apps to Promote Weight Loss and Increase Physical Activity: A Systematic Review and Meta-Analysis25.201
Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus25.201
Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis25.201
Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review25.201
Egg Consumption and Human Cardio-Metabolic Health in People with and without Diabetes25.201
Hyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs25.201
Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review25.201
Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology25.201
The role of genes involved in lipolysis on weight loss program in overweight and obese individuals25.201
You Lose Some, You Win Some: Weight Loss Induces Microbiota and Metabolite Shifts25.201
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea25.201
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity25.201
The role of fatty acids in insulin resistance25.201
Is immunity a mechanism contributing to statin-induced diabetes?25.201
FGF21, energy expenditure and weight loss – How much brown fat do you need?25.201
Lifestyle Medicine Education25.201
The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups25.201
Effect of non-surgical, non-pharmacological weight loss interventions in patients who are obese prior to hip and knee arthroplasty surgery: a rapid review25.201
Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma25.201
Metabolic disorders in menopause25.201
Vitamin paradox in obesity: Deficiency or excess?25.201
Magnesium and type 2 diabetes25.201
Vascular stiffness in insulin resistance and obesity25.201
Longitudinal omics modeling and integration in clinical metabonomics research: challenges in childhood metabolic health research25.201
Population-Based Studies on the Epidemiology of Insulin Resistance in Children25.201
Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?25.201
Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?25.201
Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration25.201
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond25.201
Diabetic Nephropathy without Diabetes25.201
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy25.201
Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction25.201
Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance25.201
Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance25.201
Dietary Advanced Glycation End Products and Their Role in Health and Disease25.201
Type‐2 diabetes: Current understanding and future perspectives25.201
Adverse Effects of GLP-1 Receptor Agonists25.201
Redox implications in adipose tissue (dys)function—A new look at old acquaintances25.201
Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease25.201
Weight Loss Instead of Weight Gain within the Guidelines in Obese Women during Pregnancy: A Systematic Review and Meta-Analyses of Maternal and Infant Outcomes25.201
Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux25.201
Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?25.201
The therapy of insulin resistance in other diseases besides type 2 diabetes25.201
Insulin receptor signaling in normal and insulin-resistant states25.201
ANIMAL MODELS OF DISEASE: Classification and etiology of diabetes in dogs and cats25.201
GLP-1 receptor agonists: a review of head-to-head clinical studies25.201
The interplay of autoimmunity and insulin resistance in type 1 diabetes25.201
Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium25.201
Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: multiple trauma patient25.201
Weight loss and bone mineral density25.201
Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales25.201
Nutritional Modulation of Insulin Resistance25.201
Progress on relationship between exercise improving insulin resistance and AMP-activated protein kinase25.201
The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin Resistance25.201
Obesity and insulin resistance: an abridged molecular correlation25.201
Nonalcoholic fatty liver disease and risk of diabetes and cardiovascular disease: What is important for primary care physicians?25.201
The use of theory in research on nutrition guidance practices by primary care physicians from 1995 to October 2008: a review25.201
Endocrine regulation of fetal skeletal muscle growth: impact on future metabolic health25.201
Obesity Associated Hypertension: New Insights into Mechanism25.201
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile25.201
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis25.201
Brain responses to food and weight loss25.201
Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials25.201
Ubiquitin ligase Cbl-b and obesity-induced insulin resistance [Review]25.201
Weight loss maintenance: A review on dietary related strategies25.201
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states25.201
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus25.201
Q2682998425.201
Journal of lifestyle medicine25.201
Weight loss in children and adolescents25.201
Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions25.201
Interplay between lipids and branched-chain amino acids in development of insulin resistance25.201
Targeting inflammation in diabetes: Newer therapeutic options25.201
The links between insulin resistance, diabetes, and cancer25.201
Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models?25.201
Parkinson's disease, insulin resistance and novel agents of neuroprotection25.201
Fatty acids, obesity, and insulin resistance: time for a reevaluation25.201
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes25.201
Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: septic patient25.201
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity25.201
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective25.201
Dietary Sodium Reduction Does Not Affect Circulating Glucose Concentrations in Fasting Children or Adults: Findings from a Systematic Review and Meta-Analysis25.201
Metabolic syndrome, insulin resistance, circadian disruption, antioxidants and pancreatic carcinoma: an overview25.201
Effectiveness of behavioural weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis25.201
Effectiveness of Weight Loss Interventions for Obese Older Adults25.201
Mechanisms of Weight Regain following Weight Loss25.201
Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes25.201
Something old, something new and something very old: drugs for treating type 2 diabetes25.201
Insulin resistance in clinical and experimental alcoholic liver disease25.201
Q2686613125.201
The downside of weight loss: realistic intervention in body-weight trajectory25.201
Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease25.201
Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes25.201
Clues from bariatric surgery: reversing insulin resistance to heal the heart25.201
Alcohol, insulin resistance and the liver–brain axis25.201
Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery25.201
Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport25.201
Alzheimer's disease and insulin resistance: translating basic science into clinical applications25.201
What are the benefits of medical screening and surveillance?25.201
Determinants of shortened, disrupted, and mistimed sleep and associated metabolic health consequences in healthy humans25.201
Thyroid Hormones and the Metabolic Syndrome25.201
The effect of physical activity on weight loss25.201
Self-directed interventions to promote weight loss: a systematic review of reviews25.201
Selection of the appropriate method for the assessment of insulin resistance25.201
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines25.201
Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: gastrointestinal surgery25.201
Vascular smooth muscle cells and monocyte-macrophages accomplice in the accelerated atherosclerosis of insulin resistance states25.201
MECHANISMS IN ENDOCRINOLOGY: Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients25.201
Psychological benefits of weight loss following behavioural and/or dietary weight loss interventions. A systematic research review25.201
Barriers to and Facilitators of Long Term Weight Loss Maintenance in Adult UK People: A Thematic Analysis25.201
Acylcarnitines: reflecting or inflicting insulin resistance?25.201
Measuring Outcomes in Adult Weight Loss Studies That Include Diet and Physical Activity: A Systematic Review25.201
Q2700465025.201
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?25.201
Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature25.201
Weight loss in obese adults 65years and older: A review of the controversy25.201
Metabolic and Glycemic Sequelae of Sleep Disturbances in Children and Adults25.201
Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome25.201
SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease25.201
Obesity and weight loss could alter the properties of adipose stem cells?25.201
Diabetes, insulin resistance, and metabolic syndrome in horses25.201
Hyperglycemia and Insulin Resistance and the Risk of BPH/LUTS: an Update of Recent Literature25.201
Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction25.201
Insulin Resistance, Hyperglycemia, and Atherosclerosis25.201
Periconception weight loss: common sense for mothers, but what about for babies?25.201
Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis25.201
Brain Insulin Resistance in Alzheimer's Disease and its Potential Treatment with GLP-1 Analogs25.201
Body Image Change in Obese and Overweight Persons Enrolled in Weight Loss Intervention Programs: A Systematic Review and Meta-Analysis25.201
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights25.201
Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery25.201
Bile acids, obesity, and the metabolic syndrome25.201
Cryolipolysis for noninvasive body contouring: clinical efficacy and patient satisfaction25.201
Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease25.201
Insulin resistance and environmental pollutants: experimental evidence and future perspectives25.201
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease25.201
The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysis25.201
A review of the use of the 5 A's model for weight loss counselling: differences between physician practice and patient demand25.201
Emerging role of protein kinase C in energy homeostasis: A brief overview25.201
A non-traditional model of the metabolic syndrome: the adaptive significance of insulin resistance in fasting-adapted seals25.201
Q2702231725.201
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis25.201
MicroRNAs in insulin resistance and obesity25.201
Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review25.201
Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin25.201
Transcriptional Regulation of Fibroblast Growth Factor 21 Expression25.201
A systematic review and meta-analysis of the association between depression and insulin resistance25.201
Dyslipidemia in women with polycystic ovary syndrome25.201
Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: oncohematological patient25.201
A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses25.201
Genetic and epigenetic control of metabolic health25.201
The role of omega-3 fatty acid receptor GPR120 in insulin resistance25.201
Myeloid heme oxygenase-1 haploinsufficiency reduces high fat diet-induced insulin resistance by affecting adipose macrophage infiltration in mice25.201
High Sugar-Induced Insulin Resistance in Drosophila Relies on the Lipocalin Neural Lazarillo25.201
Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance25.201
Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes25.201
No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic mice25.201
Improving metabolic health in obese male mice via diet and exercise restores embryo development and fetal growth25.201
Mechanisms of change of a novel weight loss programme provided by a third sector organisation: a qualitative interview study.25.201
Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes25.201
Hepatic Circadian-Clock System Altered by Insulin Resistance, Diabetes and Insulin Sensitizer in Mice25.201
Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits25.201
Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice25.201
Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice25.201
Deletion of macrophage Vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice25.201
Examination of whether early weight loss predicts 1-year weight loss among those enrolled in an Internet-based weight loss program25.201
Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance25.201
Celastrol, an NF-κB Inhibitor, Improves Insulin Resistance and Attenuates Renal Injury in db/db Mice25.201
Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis25.201
Decoration of intramyocellular lipid droplets with PLIN5 modulates fasting-induced insulin resistance and lipotoxicity in humans25.201
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism25.201
Weight change in pediatric TennCare recipients referred to a commercial weight loss program25.201
Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance25.201
Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder..25.201
Intestinal activation of Notch signaling induces rapid onset hepatic steatosis and insulin resistance25.201
GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance25.201
Evodiamine Inhibits Insulin-Stimulated mTOR-S6K Activation and IRS1 Serine Phosphorylation in Adipocytes and Improves Glucose Tolerance in Obese/Diabetic Mice25.201
The weight loss blogosphere: an online survey of weight loss bloggers.25.201
Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance25.201
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C25.201
Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein25.201
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease25.201
Drug-induced liver injury due to “natural products” used for weight loss: A case report25.201
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis25.201
Molecular mechanisms of insulin resistance in chronic hepatitis C25.201
Host Genetics, Steatosis and Insulin Resistance among African Americans and Caucasian Americans with Hepatitis C Virus Genotype-1 Infection25.201
1,000 entitysAll results shown